{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T05:06:44Z","timestamp":1764997604302,"version":"3.40.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s00277-024-05817-6","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T09:45:49Z","timestamp":1717062349000},"page":"2429-2443","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immunophenotypic classification regarding prognosis in peripheral T cell lymphoma, NOS, and nodal T follicular helper T cell lymphoma, angioimmunoblastic-type"],"prefix":"10.1007","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1569-6592","authenticated-orcid":false,"given":"Soyeon","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6014-7977","authenticated-orcid":false,"given":"Jae-Cheol","family":"Jo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9106-9326","authenticated-orcid":false,"given":"Yoo Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0406-4469","authenticated-orcid":false,"given":"Seoung Wan","family":"Chae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8744-5747","authenticated-orcid":false,"given":"Hee Jeong","family":"Cha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,30]]},"reference":[{"issue":"2","key":"5817_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.blre.2015.08.003","volume":"30","author":"J Iqbal","year":"2016","unstructured":"Iqbal J, Wilcox R, Naushad H, Rohr J, Heavican TB, Wang C, Bouska A, Fu K, Chan WC, Vose JM (2016) Genomic signatures in T-cell lymphoma: how can these improve precision in diagnosis and inform prognosis? Blood Rev 30(2):89\u2013100. https:\/\/doi.org\/10.1016\/j.blre.2015.08.003","journal-title":"Blood Rev"},{"issue":"19","key":"5817_CR2","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","volume":"123","author":"J Iqbal","year":"2014","unstructured":"Iqbal J, Wright G, Wang C, Rosenwald A, Gascoyne RD, Weisenburger DD, Greiner TC, Smith L, Guo S, Wilcox RA, Teh BT, Lim ST, Tan SY, Rimsza LM, Jaffe ES, Campo E, Martinez A, Delabie J, Braziel RM, Cook JR, Tubbs RR, Ott G, Geissinger E, Gaulard P, Piccaluga PP, Pileri SA, Au WY, Nakamura S, Seto M, Berger F, de Leval L, Connors JM, Armitage J, Vose J, Chan WC, Staudt LM, Lymphoma Leukemia Molecular Profiling P, the International Peripheral TcLP (2014) Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma. Blood 123(19):2915\u20132923. https:\/\/doi.org\/10.1182\/blood-2013-11-536359","journal-title":"Blood"},{"issue":"24","key":"5817_CR3","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1182\/blood.2019000779","volume":"134","author":"C Amador","year":"2019","unstructured":"Amador C, Greiner TC, Heavican TB, Smith LM, Galvis KT, Lone W, Bouska A, D\u2019Amore F, Pedersen MB, Pileri S, Agostinelli C, Feldman AL, Rosenwald A, Ott G, Mottok A, Savage KJ, de Leval L, Gaulard P, Lim ST, Ong CK, Ondrejka SL, Song J, Campo E, Jaffe ES, Staudt LM, Rimsza LM, Vose J, Weisenburger DD, Chan WC, Iqbal J (2019) Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry. Blood 134(24):2159\u20132170. https:\/\/doi.org\/10.1182\/blood.2019000779","journal-title":"Blood"},{"issue":"1","key":"5817_CR4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/bjh.16428","volume":"189","author":"MA Timmins","year":"2020","unstructured":"Timmins MA, Wagner SD, Ahearne MJ (2020) The new biology of PTCL-NOS and AITL: current status and future clinical impact. Br J Haematol 189(1):54\u201366. https:\/\/doi.org\/10.1111\/bjh.16428","journal-title":"Br J Haematol"},{"issue":"4","key":"5817_CR5","doi-asserted-by":"publisher","first-page":"e148","DOI":"10.3324\/haematol.2016.158428","volume":"102","author":"MP Dobay","year":"2017","unstructured":"Dobay MP, Lemonnier F, Missiaglia E, Bastard C, Vallois D, Jais JP, Scourzic L, Dupuy A, Fataccioli V, Pujals A, Parrens M, Le Bras F, Rousset T, Picquenot JM, Martin N, Haioun C, Delarue R, Bernard OA, Delorenzi M, de Leval L, Gaulard P (2017) Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin. Haematologica 102(4):e148\u2013e151. https:\/\/doi.org\/10.3324\/haematol.2016.158428","journal-title":"Haematologica"},{"issue":"6","key":"5817_CR6","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1097\/PAS.0b013e3182785610","volume":"37","author":"A Nicolae","year":"2013","unstructured":"Nicolae A, Pittaluga S, Venkataraman G, Vijnovich-Baron A, Xi L, Raffeld M, Jaffe ES (2013) Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin\/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist. Am J Surg Pathol 37(6):816\u2013826. https:\/\/doi.org\/10.1097\/PAS.0b013e3182785610","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"5817_CR7","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood.2022015851","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC, Brousset P, Cerroni L, de Leval L, Dirnhofer S, Dogan A, Feldman AL, Fend F, Friedberg JW, Gaulard P, Ghia P, Horwitz SM, King RL, Salles G, San-Miguel J, Seymour JF, Treon SP, Vose JM, Zucca E, Advani R, Ansell S, Au WY, Barrionuevo C, Bergsagel L, Chan WC, Cohen JI, d\u2019Amore F, Davies A, Falini B, Ghobrial IM, Goodlad JR, Gribben JG, Hsi ED, Kahl BS, Kim WS, Kumar S, LaCasce AS, Laurent C, Lenz G, Leonard JP, Link MP, Lopez-Guillermo A, Mateos MV, Macintyre E, Melnick AM, Morschhauser F, Nakamura S, Narbaitz M, Pavlovsky A, Pileri SA, Piris M, Pro B, Rajkumar V, Rosen ST, Sander B, Sehn L, Shipp MA, Smith SM, Staudt LM, Thieblemont C, Tousseyn T, Wilson WH, Yoshino T, Zinzani PL, Dreyling M, Scott DW, Winter JN, Zelenetz AD (2022) The International Consensus classification of mature lymphoid neoplasms: a report from the Clinical Advisory Committee. Blood 140(11):1229\u20131253. https:\/\/doi.org\/10.1182\/blood.2022015851","journal-title":"Blood"},{"key":"5817_CR8","doi-asserted-by":"publisher","unstructured":"Pileri SA, Tabanelli V, Fiori S, Calleri A, Melle F, Motta G, Lorenzini D, Tarella C, Derenzini E (2021) Peripheral T-Cell lymphoma, not otherwise specified: clinical manifestations, diagnosis, and Future Treatment. Cancers (Basel) 13(18). https:\/\/doi.org\/10.3390\/cancers13184535","DOI":"10.3390\/cancers13184535"},{"issue":"15","key":"5817_CR9","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1182\/blood-2018-09-872549","volume":"133","author":"TB Heavican","year":"2019","unstructured":"Heavican TB, Bouska A, Yu J, Lone W, Amador C, Gong Q, Zhang W, Li Y, Dave BJ, Nairismagi ML, Greiner TC, Vose J, Weisenburger DD, Lachel C, Wang C, Fu K, Stevens JM, Lim ST, Ong CK, Gascoyne RD, Missiaglia E, Lemonnier F, Haioun C, Hartmann S, Pedersen MB, Laginestra MA, Wilcox RA, Teh BT, Yoshida N, Ohshima K, Seto M, Rosenwald A, Ott G, Campo E, Rimsza LM, Jaffe ES, Braziel RM, d\u2019Amore F, Inghirami G, Bertoni F, de Leval L, Gaulard P, Staudt LM, McKeithan TW, Pileri S, Chan WC, Iqbal J (2019) Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma. Blood 133(15):1664\u20131676. https:\/\/doi.org\/10.1182\/blood-2018-09-872549","journal-title":"Blood"},{"issue":"19","key":"5817_CR10","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1182\/blood-2013-12-544809","volume":"123","author":"T Wang","year":"2014","unstructured":"Wang T, Feldman AL, Wada DA, Lu Y, Polk A, Briski R, Ristow K, Habermann TM, Thomas D, Ziesmer SC, Wellik LE, Lanigan TM, Witzig TE, Pittelkow MR, Bailey NG, Hristov AC, Lim MS, Ansell SM, Wilcox RA (2014) GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features. Blood 123(19):3007\u20133015. https:\/\/doi.org\/10.1182\/blood-2013-12-544809","journal-title":"Blood"},{"issue":"11","key":"5817_CR11","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1038\/bjc.2017.356","volume":"117","author":"S Aras","year":"2017","unstructured":"Aras S, Zaidi MR (2017) TAMeless traitors: macrophages in cancer progression and metastasis. Br J Cancer 117(11):1583\u20131591. https:\/\/doi.org\/10.1038\/bjc.2017.356","journal-title":"Br J Cancer"},{"key":"5817_CR12","doi-asserted-by":"publisher","first-page":"100889","DOI":"10.1016\/j.blre.2021.100889","volume":"52","author":"A Mina","year":"2022","unstructured":"Mina A, Pro B (2022) T time: emerging and new therapies for peripheral T-cell lymphoma. Blood Rev 52:100889. https:\/\/doi.org\/10.1016\/j.blre.2021.100889","journal-title":"Blood Rev"},{"issue":"8","key":"5817_CR13","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1002\/ajh.26270","volume":"96","author":"JM Zain","year":"2021","unstructured":"Zain JM, Hanona P (2021) Aggressive T-cell lymphomas: 2021 updates on diagnosis, risk stratification and management. Am J Hematol 96(8):1027\u20131046. https:\/\/doi.org\/10.1002\/ajh.26270","journal-title":"Am J Hematol"},{"key":"5817_CR14","doi-asserted-by":"publisher","first-page":"797028","DOI":"10.3389\/fonc.2021.797028","volume":"11","author":"TY Kim","year":"2021","unstructured":"Kim TY, Min GJ, Jeon YW, Park SS, Park S, Shin SH, Yahng SA, Yoon JH, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Kim HJ, Min CK, Lee JW, Cho SG (2021) Impact of Epstein-Barr Virus on Peripheral T-Cell Lymphoma not otherwise specified and angioimmunoblastic T-Cell lymphoma. Front Oncol 11:797028. https:\/\/doi.org\/10.3389\/fonc.2021.797028","journal-title":"Front Oncol"},{"key":"5817_CR15","doi-asserted-by":"publisher","first-page":"869488","DOI":"10.3389\/fphar.2022.869488","volume":"13","author":"X Chen","year":"2022","unstructured":"Chen X, Wu W, Wei W, Zou L (2022) Immune checkpoint inhibitors in Peripheral T-Cell Lymphoma. Front Pharmacol 13:869488. https:\/\/doi.org\/10.3389\/fphar.2022.869488","journal-title":"Front Pharmacol"},{"issue":"Suppl 5","key":"5817_CR16","doi-asserted-by":"publisher","first-page":"v108","DOI":"10.1093\/annonc\/mdv201","volume":"26","author":"F d\u2019Amore","year":"2015","unstructured":"d\u2019Amore F, Gaulard P, Trumper L, Corradini P, Kim WS, Specht L, Bjerregaard Pedersen M, Ladetto M, Committee EG (2015) Peripheral T-cell lymphomas: ESMO Clinical Practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 26(Suppl 5):v108\u2013115. https:\/\/doi.org\/10.1093\/annonc\/mdv201","journal-title":"Ann Oncol"},{"key":"5817_CR17","doi-asserted-by":"publisher","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA, Alliance AL, Lymphoma G, Eastern Cooperative Oncology G, European Mantle Cell Lymphoma C, Italian Lymphoma F, European Organisation for R, Treatment of Cancer\/Dutch Hemato-Oncology G, Grupo Espanol de Medula O, German High-Grade Lymphoma Study G, German Hodgkin\u2019s Study G, Japanese Lymphorra Study G, Lymphoma Study A, Group NCT, Nordic Lymphoma Study, Southwest Oncology G, G, United Kingdom National Cancer Research I (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32 (27):3059\u20133068. https:\/\/doi.org\/10.1200\/JCO.2013.54.8800","DOI":"10.1200\/JCO.2013.54.8800"},{"key":"5817_CR18","doi-asserted-by":"publisher","unstructured":"Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, Coiffier B, Fisher RI, Hagenbeek A, Zucca E, Rosen ST, Stroobants S, Lister TA, Hoppe RT, Dreyling MC, Tobinai K, Vose JM, Connors JM, Federico M, Diehl V, International Harmonization Project on L (2007) #37}. (2007) Revised response criteria for malignant lymphoma. J Clin Oncol 25 (5):579\u2013586. https:\/\/doi.org\/10.1200\/JCO.2006.09.2403","DOI":"10.1200\/JCO.2006.09.2403"},{"issue":"4","key":"5817_CR19","first-page":"1121","volume":"11","author":"A Delgado","year":"2021","unstructured":"Delgado A, Guddati AK (2021) Clinical endpoints in oncology - a primer. Am J Cancer Res 11(4):1121\u20131131","journal-title":"Am J Cancer Res"},{"key":"5817_CR20","unstructured":"WHO Classification of Tumours Editorial Board Haematolymphoid tumours [Internet]. Lyon (France): International Agency for Research on Cancer; (2024) (WHO classification of tumours series, 5th ed.; vol. 11). https:\/\/tumourclassification.iarc.who.int\/chapters\/63"},{"issue":"1","key":"5817_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40164-021-00224-3","volume":"10","author":"SE Yoon","year":"2021","unstructured":"Yoon SE, Cho J, Kim YJ, Ko YH, Park WY, Kim SJ, Kim WS (2021) Comprehensive analysis of clinical, pathological, and genomic characteristics of follicular helper T-cell derived lymphomas. Exp Hematol Oncol 10(1):33. https:\/\/doi.org\/10.1186\/s40164-021-00224-3","journal-title":"Exp Hematol Oncol"},{"issue":"24","key":"5817_CR22","doi-asserted-by":"publisher","first-page":"5588","DOI":"10.1182\/bloodadvances.2021005171","volume":"5","author":"M Rodriguez","year":"2021","unstructured":"Rodriguez M, Alonso-Alonso R, Tomas-Roca L, Rodriguez-Pinilla SM, Manso-Alonso R, Cereceda L, Borregon J, Villaescusa T, Cordoba R, Sanchez-Beato M, Fernandez-Miranda I, Betancor I, Barcena C, Garcia JF, Mollejo M, Garcia-Cosio M, Martin-Acosta P, Climent F, Caballero D, de la Fuente L, Minguez P, Kessler L, Scholz C, Gualberto A, Mondejar R, Piris MA (2021) Peripheral T-cell lymphoma: molecular profiling recognizes subclasses and identifies prognostic markers. Blood Adv 5(24):5588\u20135598. https:\/\/doi.org\/10.1182\/bloodadvances.2021005171","journal-title":"Blood Adv"},{"key":"5817_CR23","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3389\/fgene.2019.00780","volume":"10","author":"M Etebari","year":"2019","unstructured":"Etebari M, Navari M, Agostinelli C, Visani A, Peron C, Iqbal J, Inghirami G, Piccaluga PP (2019) Transcriptional Analysis of Lennert Lymphoma reveals a Unique Profile and identifies novel therapeutic targets. Front Genet 10:780. https:\/\/doi.org\/10.3389\/fgene.2019.00780","journal-title":"Front Genet"},{"issue":"8","key":"5817_CR24","doi-asserted-by":"publisher","first-page":"e1001633","DOI":"10.1371\/journal.pbio.1001633","volume":"11","author":"M Peine","year":"2013","unstructured":"Peine M, Rausch S, Helmstetter C, Frohlich A, Hegazy AN, Kuhl AA, Grevelding CG, Hofer T, Hartmann S, Lohning M (2013) Stable T-bet(+)GATA-3(+) Th1\/Th2 hybrid cells arise in vivo, can develop directly from naive precursors, and limit immunopathologic inflammation. PLoS Biol 11(8):e1001633. https:\/\/doi.org\/10.1371\/journal.pbio.1001633","journal-title":"PLoS Biol"},{"key":"5817_CR25","doi-asserted-by":"publisher","first-page":"928018","DOI":"10.3389\/fimmu.2022.928018","volume":"13","author":"P Burt","year":"2022","unstructured":"Burt P, Peine M, Peine C, Borek Z, Serve S, Flossdorf M, Hegazy AN, Hofer T, Lohning M, Thurley K (2022) Dissecting the dynamic transcriptional landscape of early T helper cell differentiation into Th1, Th2, and Th1\/2 hybrid cells. Front Immunol 13:928018. https:\/\/doi.org\/10.3389\/fimmu.2022.928018","journal-title":"Front Immunol"},{"issue":"1","key":"5817_CR26","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.immuni.2009.12.004","volume":"32","author":"AN Hegazy","year":"2010","unstructured":"Hegazy AN, Peine M, Helmstetter C, Panse I, Frohlich A, Bergthaler A, Flatz L, Pinschewer DD, Radbruch A, Lohning M (2010) Interferons direct Th2 cell reprogramming to generate a stable GATA-3(+)T-bet(+) cell subset with combined Th2 and Th1 cell functions. Immunity 32(1):116\u2013128. https:\/\/doi.org\/10.1016\/j.immuni.2009.12.004","journal-title":"Immunity"},{"issue":"1","key":"5817_CR27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00428-020-02790-z","volume":"477","author":"S Kim","year":"2020","unstructured":"Kim S, Kwon D, Koh J, Nam SJ, Kim YA, Kim TM, Kim CW, Jeon YK (2020) Clinicopathological features of programmed cell death-1 and programmed cell death-ligand-1 expression in the tumor cells and tumor microenvironment of angioimmunoblastic T cell lymphoma and peripheral T cell lymphoma not otherwise specified. Virchows Arch 477(1):131\u2013142. https:\/\/doi.org\/10.1007\/s00428-020-02790-z","journal-title":"Virchows Arch"},{"issue":"1","key":"5817_CR28","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/s41392-023-01622-1","volume":"8","author":"MZ Qiu","year":"2023","unstructured":"Qiu MZ, Wang C, Wu Z, Zhao Q, Zhao Z, Huang CY, Wu W, Yang LQ, Zhou ZW, Zheng Y, Pan HM, Liu Z, Zeng ZL, Luo HY, Wang F, Wang FH, Yang SY, Huang MX, Lian Z, Zhang H, Xu RH (2023) Dynamic single-cell mapping unveils Epstein\u2013Barr virus-imprinted T-cell exhaustion and on-treatment response. Signal Transduct Target Ther 8(1):370. https:\/\/doi.org\/10.1038\/s41392-023-01622-1","journal-title":"Signal Transduct Target Ther"},{"key":"5817_CR29","doi-asserted-by":"publisher","unstructured":"Salnikov MY, Fonseca GJ, Mymryk JS (2023) Differences in the Tumor Microenvironment of EBV-Associated gastric cancers revealed using single-cell transcriptome analysis. Cancers (Basel) 15(12). https:\/\/doi.org\/10.3390\/cancers15123178","DOI":"10.3390\/cancers15123178"},{"issue":"66","key":"5817_CR30","doi-asserted-by":"publisher","first-page":"110693","DOI":"10.18632\/oncotarget.22690","volume":"8","author":"J Bai","year":"2017","unstructured":"Bai J, Gao Z, Li X, Dong L, Han W, Nie J (2017) Regulation of PD-1\/PD-L1 pathway and resistance to PD-1\/PD-L1 blockade. Oncotarget 8(66):110693\u2013110707. https:\/\/doi.org\/10.18632\/oncotarget.22690","journal-title":"Oncotarget"},{"key":"5817_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2023.09.002","author":"MT Bilgihan","year":"2023","unstructured":"Bilgihan MT, Eryigit AN, Ciftciler R (2023) Efficacy and safety of Immune checkpoint inhibitors in hematologic malignancies. Clin Lymphoma Myeloma Leuk. https:\/\/doi.org\/10.1016\/j.clml.2023.09.002","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"16","key":"5817_CR32","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1182\/blood.2023021283","volume":"142","author":"GP Collins","year":"2023","unstructured":"Collins GP (2023) Tackling PD1i resistance in Hodgkin lymphoma. Blood 142(16):1333\u20131334. https:\/\/doi.org\/10.1182\/blood.2023021283","journal-title":"Blood"},{"key":"5817_CR33","doi-asserted-by":"publisher","first-page":"100974","DOI":"10.1016\/j.drup.2023.100974","volume":"69","author":"Z Zhu","year":"2023","unstructured":"Zhu Z, Shen H, Xu J, Fang Z, Wo G, Ma Y, Yang K, Wang Y, Yu Q, Tang JH (2023) GATA3 mediates doxorubicin resistance by inhibiting CYB5R2-catalyzed iron reduction in breast cancer cells. Drug Resist Updat 69:100974. https:\/\/doi.org\/10.1016\/j.drup.2023.100974","journal-title":"Drug Resist Updat"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05817-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05817-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05817-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T16:07:24Z","timestamp":1720109244000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05817-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,30]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["5817"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05817-6","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2024,5,30]]},"assertion":[{"value":"29 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional review board (IRB) of Ulsan University Hospital (IRB No. 2022-09-029).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors have declared no conflicts of interest related to this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}